Nuclein
Latest round
- Series B
Last raised
- Mar 2021
Total raised
- $14M
Investors
- 1
About Nuclein
Based in Texas, US, and founded in 2017, Nuclein, LLC is a medical device company that develops hand-held polymerase chain reaction (PCR) test designed to be a disposable, all-in-one, and self-test for infectious disease diagnosis. Nuclein hand-held PCR Test uses standard, real-time PCR and does not require technical expertise. The device is battery-powered and produces quick results in under one hour without the need to mail in a sample. Nuclein plans to apply to the U. S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) to commercialize its COVID-19 testing device, and hire additional molecular biologists, engineers, and manufacturing staff to support its growth.
Who invested in Nuclein
1 investor across 1 round
See all investors in Nuclein
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Mar 25, 2021
Amount
$14M
Investors
Questions about Nuclein
Who invested in Nuclein?
Nuclein has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nuclein raised?
Nuclein has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nuclein last raise money?
Nuclein's most recent round on record is a Series B, in Mar 2021.
What does Nuclein do?
Based in Texas, US, and founded in 2017, Nuclein, LLC is a medical device company that develops hand-held polymerase chain reaction (PCR) test designed to be a disposable, all-in-one, and self-test for infectious disease diagnosis.
Where is Nuclein headquartered?
Nuclein is headquartered in Austin, US.
Which VCs invest in companies like Nuclein?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nuclein's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Nuclein? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.